Habil Khorakiwala: Hard to Swallow

Habil Khorakiwala has stepped down as managing director of pharma firm Wockhardt in the wake of a debt burden and forex losses. He now retains only the chairmanship. Forbes India asks him about the tumult within the company

(A link to this page will be included in your message)


Your Name
Email Address
 Send me a copy
Recipient's Email Address
Separate multiple email addresses with commas (max 20)
Your Message
(1000 characters max)
"The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party."